skip to main content
Idioma:
Refinado por: Nome da Publicação: Blood remover assunto: Hematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Kanate, Abraham S. ; Mussetti, Alberto ; Kharfan-Dabaja, Mohamed A. ; Ahn, Kwang W. ; DiGilio, Alyssa ; Beitinjaneh, Amer ; Chhabra, Saurabh ; Fenske, Timothy S. ; Freytes, Cesar ; Gale, Robert Peter ; Ganguly, Siddhartha ; Hertzberg, Mark ; Klyuchnikov, Evgeny ; Lazarus, Hillard M. ; Olsson, Richard ; Perales, Miguel-Angel ; Rezvani, Andrew ; Riches, Marcie ; Saad, Ayman ; Slavin, Shimon ; Smith, Sonali M. ; Sureda, Anna ; Yared, Jean ; Ciurea, Stefan ; Armand, Philippe ; Salit, Rachel ; Bolaños-Meade, Javier ; Hamadani, Mehdi

Blood, 2016-02, Vol.127 (7), p.938-947 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
Material Type:
Artigo 		Adicionar ao Meu Espaço

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing

Kurtz, David M. ; Green, Michael R. ; Bratman, Scott V. ; Scherer, Florian ; Liu, Chih Long ; Kunder, Christian A. ; Takahashi, Kazuhiro ; Glover, Cynthia ; Keane, Colm ; Kihira, Shingo ; Visser, Brendan ; Callahan, Jason ; Kong, Katherine A. ; Faham, Malek ; Corbelli, Karen S. ; Miklos, David ; Advani, Ranjana H. ; Levy, Ronald ; Hicks, Rodney J. ; Hertzberg, Mark ; Ohgami, Robert S. ; Gandhi, Maher K. ; Diehn, Maximilian ; Alizadeh, Ash A.

Blood, 2015-06, Vol.125 (24), p.3679-3687 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
Material Type:
Artigo 		Adicionar ao Meu Espaço

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

Iland, Harry J. ; Bradstock, Ken ; Supple, Shane G. ; Catalano, Alberto ; Collins, Marnie ; Hertzberg, Mark ; Browett, Peter ; Grigg, Andrew ; Firkin, Frank ; Hugman, Amanda ; Reynolds, John ; Di Iulio, Juliana ; Tiley, Campbell ; Taylor, Kerry ; Filshie, Robin ; Seldon, Michael ; Taper, John ; Szer, Jeff ; Moore, John ; Bashford, John ; Seymour, John F.

Blood, 2012-08, Vol.120 (8), p.1570-1580 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML

Branford, Susan ; Yeung, David T. ; Ross, David M. ; Prime, Jodi A. ; Field, Chani R. ; Altamura, Haley K. ; Yeoman, Alexandra L. ; Georgievski, Jasmina ; Jamison, Bronte A. ; Phillis, Stuart ; Sullivan, Brad ; Briggs, Nancy E. ; Hertzberg, Mark ; Seymour, John F. ; Reynolds, John ; Hughes, Timothy P.

Blood, 2013-05, Vol.121 (19), p.3818-3824 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy

Schnegg-Kaufmann, Annatina S. ; Thoms, Julie A. I. ; Bhuyan, Golam Sarower ; Hampton, Henry R. ; Vaughan, Lachlin ; Rutherford, Kayleigh ; Kakadia, Purvi M. ; Lee, Hui Mei ; Johansson, Emma M. V. ; Failes, Timothy W. ; Arndt, Greg M. ; Koval, Jason ; Lindeman, Robert ; Warburton, Pauline ; Rodriguez-Meira, Alba ; Mead, Adam J. ; Unnikrishnan, Ashwin ; Davidson, Sarah ; Polizzotto, Mark N. ; Hertzberg, Mark ; Papaemmanuil, Elli ; Bohlander, Stefan K. ; Faridani, Omid R. ; Jolly, Christopher J. ; Zanini, Fabio ; Pimanda, John E.

Blood, 2023-03, Vol.141 (11), p.1316-1321 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Structure and function of the von Willebrand factor A1 domain : analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation
Structure and function of the von Willebrand factor A1 domain : analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Structure and function of the von Willebrand factor A1 domain : analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation

DE LUCA, M ; FACEY, D. A ; FAVALORO, E. J ; HERTZBERG, M. S ; WHISSTOCK, J. C ; MCNALLY, T ; ANDREWS, R. K ; BERNDT, M. C

Blood, 2000, Vol.95 (1), p.164-172 [Periódico revisado por pares]

Washington, DC: The Americain Society of Hematology

Texto completo disponível

Citações Citado por
7
Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial
Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial

Lee, Jong Wook ; Yoon, Sung-Soo ; Xiang Shen, Zhi ; Ganser, Arnold ; Hsu, Hui-Chi ; Habr, Dany ; Domokos, Gabor ; Roubert, Bernard ; Porter, John B.

Blood, 2010-10, Vol.116 (14), p.2448-2454 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.